Medication development for addictive disorders: the state of the science.
about
Naltrexone for cocaine dependence treatmentNaltrexone for cocaine dependence treatmentLower reinforcing strength of the phenyltropane cocaine analogs RTI-336 and RTI-177 compared to cocaine in nonhuman primatesChronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitorsBehavioral and neurochemical effects of amphetamine analogs that release monoamines in the squirrel monkeyDopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addictionDevelopment and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusers.New developments in the pharmacotherapy of cocaine abuseThalamo-cortical dysfunction in cocaine abusers: implications in attention and perception.Stimulants as specific inducers of dopamine-independent σ agonist self-administration in ratsCharacterizing longitudinal health state transitions among heroin, cocaine, and methamphetamine users.Opioid dependence treatment: options in pharmacotherapy.Anti-cocaine vaccine development.Effects of extended cocaine access and cocaine withdrawal on choice between cocaine and food in rhesus monkeys.Management of HIV infection in patients with substance use problemsLevo-tetrahydropalmatine attenuates cocaine self-administration under a progressive-ratio schedule and cocaine discrimination in ratsLost in translation? Moving contingency management and cognitive behavioral therapy into clinical practiceAlpha-ethyltryptamines as dual dopamine-serotonin releasersHormones, nicotine, and cocaine: clinical studies.Neuroscience of behavioral and pharmacological treatments for addictionsInfluence of cocaine history on the behavioral effects of Dopamine D(3) receptor-selective compounds in monkeys.Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analoguesBehavioral evaluation of modafinil and the abuse-related effects of cocaine in rhesus monkeys.Chronic stress, drug use, and vulnerability to addiction.Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapseReduction of the reinforcing effectiveness of cocaine by continuous D-amphetamine treatment in rats: importance of active self-administration during treatment periodGenetic Association Analysis of NOS3 and Methamphetamine-Induced Psychosis Among JapaneseGenetic Association Analysis of NOS1 and Methamphetamine-Induced Psychosis Among Japanese.Pharmacodynamics must inform statistics: an example from a cocaine dependence pharmacotherapy trialThe "new masculinity": addiction treatment as a reconstruction of gender in Puerto Rican evangelist street ministriesInvestigating Methamphetamine Craving Using the Extinction-Reinstatement Model in the Rat.Long-lasting effects of a PEGylated mutant cocaine esterase (CocE) on the reinforcing and discriminative stimulus effects of cocaine in rats.AAVrh.10-mediated expression of an anti-cocaine antibody mediates persistent passive immunization that suppresses cocaine-induced behavior.Repeated administration of a mutant cocaine esterase: effects on plasma cocaine levels, cocaine-induced cardiovascular activity, and immune responses in rhesus monkeys.Efficacy of disulfiram and Twelve Step Facilitation in cocaine-dependent individuals maintained on methadone: a randomized placebo-controlled trialOral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats.Reaction Pathway and Free Energy Profile for Cocaine Hydrolase-Catalyzed Hydrolysis of (-)-CocaineLorcaserin Reduces the Discriminative Stimulus and Reinforcing Effects of Cocaine in Rhesus Monkeys.Club drugs and HIV infection: a review.
P2860
Q24188333-943D544D-4705-429C-8331-B882035A904FQ24234664-68A40A6E-E8EA-42CA-A854-D59557FE9CC0Q24605771-1079038F-D5FD-40BD-A07F-4891DE3C9016Q24633835-55F5DDE2-7AAB-475C-9613-0C8FA202C9E4Q24645072-73176AE4-270F-4D81-8DBC-10DAC007B981Q24651855-6FEA81E0-81B3-4B53-928B-57B2965F28CDQ24656085-98304616-EF75-4360-8695-88493B040AB3Q25256775-590D3778-8725-49EE-A449-45298B65F28BQ28302782-96A55116-F9AA-470B-B1A4-D815CC2EE329Q30496711-8327C9BE-C82D-4295-96EF-26466AD1DA33Q30546325-B218ED79-5D98-44FA-9532-2243343D305AQ33810775-16115386-594D-4D4E-A3AC-4E32BBE10835Q33868638-22110642-DB17-4226-8337-1AFF4F4C5318Q34023863-DE0F7986-2D0F-4609-A0BF-58537AFC5333Q34033791-6365DD22-59E0-4614-9A5C-050E39340A6BQ34113784-26E07A3A-43DC-4112-8CCE-2A20050C7889Q34209414-4A322A62-6707-4DE7-A2AF-9AC0FF06EABDQ34389080-3038A1C9-925D-4466-86F4-DC54BFFF882AQ34414250-8F7B9B21-6557-442E-A883-FF4F7FEF5D37Q34643948-FA589AB9-5195-4C38-9E6D-06354B2F068FQ34714494-63BB1426-30F7-4F71-BFDB-B2F522C51287Q34762698-67517BDA-A0C7-4846-BB25-C23652E0245FQ34796464-693901F6-8F24-41B5-B7A4-2DEEE6174E39Q34817123-9E82695B-8536-4195-B769-47574C2B1553Q34875333-D2E2099B-726A-4380-B76A-2A8AE18265F5Q35062881-189E7E6D-3162-4827-B23E-E31BA4185374Q35082614-382F329B-54CB-41F7-B986-0A38E8115937Q35107770-EE31EC29-E489-4C7C-96F4-B065ACAFFE70Q35107775-B35F94D4-78CE-49A7-B933-FE8AF309EF97Q35361177-18D0EE3C-9B30-48CB-9B62-8D841814BA9BQ35621885-1AB3E9D4-218E-4F39-BA06-647C27E90E2AQ35833732-7E76E822-CA47-4850-8DF4-F57868C98FB7Q35837678-60EB3205-DC7D-4ACD-8531-1A541C5F6113Q35988700-5B7D3302-576F-4C60-A6E0-9B0EE54B4823Q36057949-685595FD-1CF5-4EF1-9A5B-5E61082C8F76Q36287820-6FEBEDD0-3858-45B6-B8AC-E268B90DF704Q36303094-8270C074-3765-43B9-99D0-695B731D2558Q36311751-72E182EA-A7D9-4C34-9DBF-ADAA2179D2F9Q36432310-1A7F2CED-D5B6-4F56-91DF-365849C96370Q36451059-54A38EFF-DF72-46B0-833E-DBDA2F1D642D
P2860
Medication development for addictive disorders: the state of the science.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Medication development for addictive disorders: the state of the science.
@ast
Medication development for addictive disorders: the state of the science.
@en
type
label
Medication development for addictive disorders: the state of the science.
@ast
Medication development for addictive disorders: the state of the science.
@en
prefLabel
Medication development for addictive disorders: the state of the science.
@ast
Medication development for addictive disorders: the state of the science.
@en
P2093
P1476
Medication development for addictive disorders: the state of the science.
@en
P2093
Ahmed Elkashef
Frank J Vocci
P304
P356
10.1176/APPI.AJP.162.8.1432
P407
P577
2005-08-01T00:00:00Z